Atrys Health, S.A. (ATRY)
BME
Real-time Data
07:00 AM
Day's Range
2.5152 wk Range
2.31Overview - ATRY - Atrys Health, S.A.
Key Statistics
Valuation
Enterprise Value
436.42M
P/E (Forward)
‪16.44‬
PEG Ratio
‪16.44‬
Price / Sales (TTM)
‪1.33‬
Price / Book
‪1.26‬
EV / EBITDA
‪69.40‬
Profitability
Profit Margin
‪-69.49%‬
Operating Margin
‪-41.77%‬
Return on Assets
‪-1.20%‬
Return on Equity
‪-27.45%‬
Ownership
Shares Outstanding
75.90M
Float
40.09M
Held by Insiders
‪56.76%‬
Held by Institutions
‪10.75%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪2.55‬
200-Day Avg
‪2.77‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
3 analysts
Average price target
‪€ 4.83‬Market Cap - ATRY - Atrys Health, S.A.
Profile Summary - ATRY - Atrys Health, S.A.
About
Atrys Health, S.A. is a Spain-based biomedical company specializing in precision diagnostic services and oncology treatments. Founded in 2007 and headquartered in Madrid, it operates through segments including Diagnosis, Oncology, and Preventive Medicine, delivering integrated solutions like structural and molecular…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
